Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies

Improved survival after acute graft- versus -host disease diagnosis in the modern era

(2017) Hanna J. Khoury et al.   HAEMATOLOGICA

Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes

(2017) Jason A. Trubiano et al.   LEUKEMIA & LYMPHOMA

Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials

(2017) Cho-Hao Lee et al.   PLoS One

New Therapeutic Strategies in Acute Lymphocytic Leukemia

(2017) Louise M. Man et al.   Current Hematologic Malignancy Reports

The Future of Targeting FLT3 Activation in AML

(2017) Mark B. Leick et al.   Current Hematologic Malignancy Reports

Improved survival after acute graft- versus -host disease diagnosis in the modern era

(2017) Hanna J. Khoury et al.   HAEMATOLOGICA

Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy

(2016) Jason N. Barreto et al.   AMERICAN JOURNAL OF HEMATOLOGY

Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation

(2016) Ola Blennow et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review

(2016) Hafsa M. Chaudhry et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis

(2016) K M Williams et al.   BONE MARROW TRANSPLANTATION

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

(2016) D Niederwieser et al.   BONE MARROW TRANSPLANTATION

CD101: a novel long-acting echinocandin

(2016) Yanan Zhao et al.   CELLULAR MICROBIOLOGY

An update on the safety and interactions of antifungal drugs in stem cell transplant recipients

(2016) Corrado Girmenia et al.   Expert Opinion On Drug Safety

Pharmacokinetic/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populations

(2016) Qianting Yang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Biology and clinical application of CAR T cells for B cell malignancies

(2016) Marco L. Davila et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

ECIL guidelines for preventingPneumocystis jiroveciipneumonia in patients with haematological malignancies and stem cell transplant recipients

(2016) Johan Maertens et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, againstCandidaandAspergillusspp., including echinocandin- and azole-resistant isolates

(2016) Michael A. Pfaller et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients

(2016) Silvia Park et al.   JOURNAL OF INFECTION

Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study

(2016) Clara Mariette et al.   LEUKEMIA & LYMPHOMA

The risk of infections in patients with myelodysplastic syndromes in 2016

(2016) Morena Caira et al.   Expert Review of Hematology

Acute myeloid leukemia-Major progress over four decades and glimpses into the future

(2015) Hagop Kantarjian   AMERICAN JOURNAL OF HEMATOLOGY

Mechanisms of echinocandin antifungal drug resistance

(2015) David S. Perlin   Annals of the New York Academy of Sciences

Antifungal Activities of SCY-078 (MK-3118) and Standard Antifungal Agents against Clinical Non-Aspergillus Mold Isolates

(2015) Frédéric Lamoth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study

(2015) Nicole Harrison et al.   BMC INFECTIOUS DISEASES

Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin

(2015) Dionysis Neofytos et al.   CLINICAL INFECTIOUS DISEASES

Antifungal-Associated Drug-Induced Cardiac Disease

(2015) John D. Cleary et al.   CLINICAL INFECTIOUS DISEASES

Echinocandins: The Expanding Antifungal Armamentarium

(2015) Daniel Aguilar-Zapata et al.   CLINICAL INFECTIOUS DISEASES

Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits

(2015) Ruta Petraitiene et al.   CLINICAL INFECTIOUS DISEASES

Potential Microbiological Effects of Higher Dosing of Echinocandins

(2015) William J. Steinbach et al.   CLINICAL INFECTIOUS DISEASES

The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality

(2015) Emily Wang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan

(2015) Jih-Luh Tang et al.   PLoS One

Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

(2014) Daniela Tacke et al.   ANNALS OF HEMATOLOGY

Effectiveness of Primary Anti-Aspergillus Prophylaxis during Remission Induction Chemotherapy of Acute Myeloid Leukemia

(2014) M. Z. R. Gomes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using anIn VivoMurine Invasive Candidiasis Model

(2014) Alexander J. Lepak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

(2014) Corrado Girmenia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO)

(2014) Corrado Girmenia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Fishing for myelodysplastic syndromes finds uncaptured cases by state cancer registries: Need for more resources

(2014) Christopher R. Cogle   CANCER

Systemic Antifungal Prophylaxis After Hematopoietic Stem Cell Transplantation: A Meta-Analysis

(2014) Panayiotis D. Ziakas et al.   CLINICAL THERAPEUTICS

Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs

(2014) J.-F. Wang et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: A 6-yr analysis from the cologne cohort for neutropenic patients

(2014) Maria J. G. T. Vehreschild et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study

(2014) David Nachbaur et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014

(2014) S. Fleming et al.   INTERNAL MEDICINE JOURNAL

Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye–Authors' reply

(2014) Roelof W F van Leeuwen et al.   LANCET ONCOLOGY

Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study

(2014) Hsiang-Chi Kung et al.   Cancer Medicine

Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization

(2013) David R. Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal Prophylaxis Associated With Decreased Induction Mortality Rates and Resources Utilized in Children With New-Onset Acute Myeloid Leukemia

(2013) B. T. Fisher et al.   CLINICAL INFECTIOUS DISEASES

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

The role of primary antifungal prophylaxis in patients with haematological malignancies

(2013) L. Pagano et al.   CLINICAL MICROBIOLOGY AND INFECTION

Characterization of a Distinct Host Response Profile to Pneumocystis murina Asci during Clearance of Pneumocystis Pneumonia

(2013) Michael J. Linke et al.   INFECTION AND IMMUNITY

A severe case of haemodynamic instability during anidulafungin administration

(2013) M. Fink et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Cardiac effects of echinocandin preparations - three case reports

(2013) C. Lichtenstern et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Therapeutic Potential of Caspofungin Combined with Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia: A Pilot Study in Mice

(2013) Maria Luísa Lobo et al.   PLoS One

Newer Antifungal Agents for Fungal Infection Prevention During Hematopoietic Cell Transplantation: A Meta-Analysis

(2013) S.-X. Xu et al.   TRANSPLANTATION PROCEEDINGS

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

(2012) M. A. Pfaller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant

(2012) Xiaojun Huang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation

(2012) N. Gokbuget et al.   BLOOD

Future Directions in Mucormycosis Research

(2012) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Risks for infection in patients with myelodysplasia and acute leukemia

(2012) Livio Pagano et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy

(2012) Dionissios Neofytos et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)

(2012) M. A. Pfaller et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

(2012) Stephen P. Hunger et al.   JOURNAL OF CLINICAL ONCOLOGY

The Increased Risk for Pneumocystis Pneumonia in Patients Receiving Rituximab-CHOP-14 Can Be Prevented by the Administration of Trimethoprim/Sulfamethoxazole: A Single-Center Experience

(2011) Emilia Hardak et al.   ACTA HAEMATOLOGICA

Importance of Pharmacokinetic Considerations for Selecting Therapy in the Treatment of Invasive Fungal Infections

(2011) Russell E Lewis   AMERICAN JOURNAL OF THERAPEUTICS

Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials

(2011) Ying-Jun Chang et al.   ANNALS OF HEMATOLOGY

Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness of Systemic Antifungal Prophylaxis in Patients With Neutropenia After Chemotherapy: A Meta-Analysis of Randomized Controlled Trials

(2011) Panayiotis D. Ziakas et al.   CLINICAL THERAPEUTICS

A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study)

(2011) C. Cattaneo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Flash pulmonary oedema during anidulafungin administration

(2011) C. B. Hindahl et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Adverse interactions between antifungal azoles and vincristine: review and analysis of cases

(2011) Brad Moriyama et al.   MYCOSES

Echinocandins in Children

(2011) Jill A. Hoffman et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Long-Term Voriconazole and Skin Cancer: Is There Cause for Concern?

(2011) Cornelius J. Clancy et al.   Current Infectious Disease Reports

Acute Myelogenous Leukemia Patients Are at Low Risk for Invasive Fungal Infections after High-Dose Cytarabine Consolidations and Thus Do Not Require Prophylaxis

(2010) Grant Lewis et al.   ACTA HAEMATOLOGICA

Invasive fungal disease in patients treated for newly diagnosed acute leukemia

(2010) Sarah P. Hammond et al.   AMERICAN JOURNAL OF HEMATOLOGY

Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study

(2010) Parinda A. Mehta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

(2010) J. R. Wingard et al.   BLOOD

Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib

(2010) A. Haouala et al.   BLOOD

Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success

(2010) D P Kontoyiannis   BONE MARROW TRANSPLANTATION

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

(2010) J Maertens et al.   BONE MARROW TRANSPLANTATION

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Echinocandin Antifungal Drugs in Fungal Infections

(2010) Sharon C.-A. Chen et al.   DRUGS

Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study

(2010) C. Even et al.   HAEMATOLOGICA

Echinocandin Treatment of Pneumocystis Pneumonia in Rodent Models Depletes Cysts Leaving Trophic Burdens That Cannot Transmit the Infection

(2010) Melanie T. Cushion et al.   PLoS One

Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation

(2009) I. Amigues et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation

(2009) C Orasch et al.   BONE MARROW TRANSPLANTATION

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

(2009) M Tomblyn et al.   BONE MARROW TRANSPLANTATION

Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients

(2009) M Mikulska et al.   BONE MARROW TRANSPLANTATION

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007)

(2009) Nikolaos V. Sipsas et al.   CANCER

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

(2009) Roger J. M. Brüggemann et al.   CLINICAL INFECTIOUS DISEASES

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Index to Predict Invasive Mold Infection in High-Risk Neutropenic Patients Based on the Area Over the Neutrophil Curve

(2009) Rodrigo D. Portugal et al.   JOURNAL OF CLINICAL ONCOLOGY

Infections in Patients With Multiple Myeloma

(2009) Marcio Nucci et al.   SEMINARS IN HEMATOLOGY

Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications

(2008) D. Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The changing epidemiology of invasive candidiasis

(2008) Ray Hachem et al.   CANCER

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

(2008) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES

Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation

(2008) Yasushi Hiramatsu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Caspofungin Modulates Inflammatory Responses toAspergillus fumigatusthrough Stage‐Specific Effects on Fungal β‐Glucan Exposure

(2008) T. M. Hohl et al.   JOURNAL OF INFECTIOUS DISEASES

No occurrence ofPneumocystis jiroveci (carinii)pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation

(2008) A. Tomonari et al.   Transplant Infectious Disease

Population pharmacokinetics of micafungin in adult patients

(2007) Tawanda Gumbo et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE